JACC: Case Reports (Jun 2024)

Novel Compound Heterozygous Variants in Trans-2,3-Enoyl-Coenzyme A Reductase-Like Gene Associated With Catecholaminergic Polymorphic Ventricular Tachycardia

  • Keiko Shimamoto, MD, PhD,
  • Naokata Sumitomo, MD, PhD,
  • Taisuke Nabeshima, MD, PhD,
  • Seiko Ohno, MD, PhD,
  • Wataru Shimizu, MD, PhD,
  • Kengo Kusano, MD, PhD,
  • Takeshi Aiba, MD, PhD

Journal volume & issue
Vol. 29, no. 11
p. 102364

Abstract

Read online

A 10-year-old female patient experienced syncope while swimming, and electrocardiography revealed polymorphic ventricular tachycardia, leading to a diagnosis of catecholaminergic polymorphic ventricular tachycardia. No pathogenic variant was identified in RYR2. Additional comprehensive genetic testing revealed novel compound heterozygous variants in trans-2,3-enoyl-coenzyme A reductase–like gene, which caused a recessive form of catecholaminergic polymorphic ventricular tachycardia.

Keywords